Added to YB: 2025-02-11
Pitch date: 2025-02-10
ROVI.MC [bullish]
Laboratorios Farmaceuticos Rovi, S.A.
+14.74%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
Market Cap
EUR 3.3B
Pitch Price
EUR 54.25
Price Target
N/A
Dividend
1.45%
EV/EBITDA
16.88
P/E
24.87
EV/Sales
4.52
Sector
Pharmaceuticals
Category
turnaround
Laboratorios Rovi (ROVI) ST struggles, LT growth still in play
ROVI.MC (overview): 2024 EBITDA 10-15% below expectations due to weak Q4 CDMO. 2025 guidance unchanged. LT growth potential in injectables CDMO. Recent sector deals (Catalent buyout) positive. PE interest in CDMO unit. Key catalyst: securing new clients. March CMD crucial for outlook. Shares down on weak comms & near-term uncertainty.
Read full article (1 min)